The groundbreaking rise of Viagra has consistently remained a example of pharmaceutical success, yet its legacy within the broader industry now triggers questions about long-term returns . Generic versions are eroding patent protection , causing worries that investing in companies heavily reliant to Viagra's previous standing could be a dangerous d